UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Tissue Selective Estrogen Complex: A Novel Approach to the Treatment of Menopausal Symptoms

Journal of women's health (Larchmont, N.Y. 2002), 2012-09, Vol.21 (9), p.975-981

Kagan, Risa

2012

Volltextzugriff (PDF)

Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States

Mayo Clinic proceedings, 2015, Vol.90 (1), p.53-62

2015

Volltextzugriff (PDF)

Efficacy and safety of erenumab in women with a history of menstrual migraine

Journal of headache and pain, 2020-08, Vol.21 (1), p.95-95, Article 95

2020

Volltextzugriff (PDF)

Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis

Journal of bone and mineral research, 2017-01, Vol.32 (1), p.3-10

2017

Volltextzugriff (PDF)

The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms

Journal of women's health (Larchmont, N.Y. 2002), 2012-09, Vol.21 (9), p.975

Kagan, Risa

2012

Volltextzugriff (PDF)

Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause

Menopause (New York, N.Y.), 2018-01, Vol.25 (1), p.106-108

2018

Volltextzugriff (PDF)

Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause

Drugs & aging, 2019-10, Vol.36 (10), p.897-908

2019

Volltextzugriff (PDF)

Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society

Menopause (New York, N.Y.), 2014-10, Vol.21 (10), p.1063-1068

2014

Volltextzugriff (PDF)

Surgical menopause: still confused after all these years

Menopause (New York, N.Y.), 2012-05, Vol.19 (5), p.491-493

Kagan, Risa

2012

Volltextzugriff (PDF)

Effects of TX-001HR in Women With Menopause [19J]

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (1), p.112-112S

2019

Volltextzugriff (PDF)

Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

Menopause (New York, N.Y.), 2024-01, Vol.31 (1), p.68

2024

Volltextzugriff (PDF)

Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women

Menopause (New York, N.Y.), 2019-06, Vol.26 (6), p.622-628

2019

Volltextzugriff (PDF)

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

Menopause (New York, N.Y.), 2022-02, Vol.29 (3), p.304-308

2022

Volltextzugriff (PDF)

Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo

Postgraduate medicine, 2018-11, Vol.130 (8), p.687-693

2018

Volltextzugriff (PDF)

The 2012 hormone therapy position statement of: The North American Menopause Society

Menopause (New York, N.Y.), 2012-03, Vol.19 (3), p.257-271

North American Menopause Society

2012

Volltextzugriff (PDF)

Effects of E2/P4 Oral Capsules on Bone Turnover in Women With Vasomotor Symptoms [06F]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.62-62S

2020

Volltextzugriff (PDF)

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Menopause (New York, N.Y.), 2018-06, Vol.25 (6), p.596-608

2018

Volltextzugriff (PDF)

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

Menopause (New York, N.Y.), 2010-03, Vol.17 (2), p.281-289

2010

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice

Maturitas, 2023-06, Vol.172, p.23-31

2023

Volltextzugriff (PDF)

Is there a time limit for systemic menopausal hormone therapy?

Cleveland Clinic journal of medicine, 2016-08, Vol.83 (8), p.605-612

2016

Volltextzugriff (PDF)

The North American Menopause Society recommendations for clinical care of midlife women

Menopause (New York, N.Y.), 2014-10, Vol.21 (10), p.1038-1062

2014

Volltextzugriff (PDF)

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause

Menopause (New York, N.Y.), 2014-06, Vol.21 (6), p.567-573

2014

Volltextzugriff (PDF)

Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use

Expert opinion on pharmacotherapy, 2015-11, Vol.16 (17), p.2703-2714

2015

Volltextzugriff (PDF)

Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials

Menopause (New York, N.Y.), 2024-06, Vol.31 (6), p.494

2024

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(66)
Buchkapitel
(1)

Sprache

Englisch
(67)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Tissue Selective Estrogen Complex: A Novel Approach to the Treatment of Menopausal Symptoms

Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States

Efficacy and safety of erenumab in women with a history of menstrual migraine

Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis

The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms

Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause

Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause

Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society

Surgical menopause: still confused after all these years

Effects of TX-001HR in Women With Menopause [19J]

Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo

The 2012 hormone therapy position statement of: The North American Menopause Society

Effects of E2/P4 Oral Capsules on Bone Turnover in Women With Vasomotor Symptoms [06F]

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice

Is there a time limit for systemic menopausal hormone therapy?

The North American Menopause Society recommendations for clinical care of midlife women

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause

Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use

Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials

Suchergebnisse filtern